09:30 Registration
10:00 Årsmötesförhandlingar (på svenska)
12:00 Registration and lunch
13:00 Welcome and introduction to the theme 2025
13:15 Lina Wendt Rasch, The Swedish Chemicals Agency
13:40 Tim Lindberg, Senzagen
14:05 Eric Wellner, AstraZeneca
14:30 Coffee break
15:00 Patrik Andersson, IVL Swedish Environmental Research Institute
15:25 Linus Wiklund, Institute of Environmental Medicine, Karolinska Institutet. Title: Using transcriptomics data and Adverse Outcome Pathway networks to explore endocrine disrupting properties of Cadmium and PCB-126
15:50 Anna Forsby, Stockholm University
16:15 Wrap-up of the day, mingle
17:00 End of the annual meeting
Joint dinner at cost price, in the area close to Karolinska Institutet.
Will be updated continuously
Linus research project is titled “A Novel Mechanism-Based Approach for Assessment of Developmental Toxicity of Endocrine Disruptors”. The project’s aim is to develop risk assessment methodology that utilizes mechanistic data from New Approach Methodologies (NAMs) to facilitate identification of developmental toxicity caused by endocrine disruptors (EDs), without using in vivo data. Linus’ research explores how Adverse Outcome Pathways (AOPs) can be used to connect mechanistic data from various NAMs to adverse outcomes, in order to predict adversity, and identifies challenges associated with this approach.
© Copyright. All Rights Reserved.